Newsfeeds - Spark Newswire

1 minute read

Belite Bio Seeks FDA Clearance For Late-Stage Genetic Eye Disease Study

Today, 6:44 PM

Belite Bio (NASDAQ: BLTE) submitted an Investigational New Drug (IND) application to the U.S. Food and Drug Administration (FDA) to support Phase 3 development of its lead asset LBS-008 for treatment of Stargardt Disease (STGD1).

BLTE

1 minute read

Benchmark Initiates Coverage On Belite Bio with Buy Rating, Announces Price Target of $57

By Benzinga Newsdesk

Today, 6:44 PM

Benchmark analyst Bruce Jackson initiates coverage on Belite Bio (NASDAQ:BLTE) with a Buy rating and announces Price Target of $57.

BLTE

3 minute read

Mid-Morning Market Update: Markets Open Higher; US Retail Sales Drop In May

By Lisa Levin

Today, 6:44 PM

U.S. stocks traded higher this morning, with the Dow Jones gaining more than 300 points on Wednesday.

ASTL

5 minute read

82 Biggest Movers From Yesterday

By Lisa Levin

Today, 6:44 PM

Gainers Comera Life Sciences Holdings, Inc. (NASDAQ: CMRA) gained 126.5% to settle at $2.65 on Tuesday.

ACLX

2 minute read

Movers

12 Health Care Stocks Moving In Tuesday’s After-Market Session

By Benzinga Insights

Today, 6:44 PM

Gainers

ACRX

4 minute read

70 Stocks Moving In Monday’s Mid-Day Session

By Lisa Levin

Today, 6:44 PM

Gainers Day One Biopharmaceuticals, Inc. (NASDAQ: DAWN) shares jumped 110% to $13.93 after the company announced initial data from the pivotal FIREFLY-1 trial of tovorafenib in relapsed pediatric low-grade glioma showed an overall response rate of 64%.

ABVC

2 minute read

The Week Ahead In Biotech (May 22-28): Verrica, Bristol-Myers Squibb FDA Decisions, Medtronic Earnings, Conference Presentations & More

By Shanthi Rexaline

Today, 6:44 PM

Biotech stocks advanced in the week ending May 22, defying the broader market retreat. The defensive nature of the industry and stock-specific moves lent support.

ABBV

6 minute read

83 Biggest Movers From Yesterday

By Lisa Levin

Today, 6:44 PM

Gainers Hudson Technologies, Inc. (NASDAQ: HDSN) shares jumped 26.9% to close at $9.06 on Thursday after the company reported better-than-expected Q1 EPS and sales results.

AENZ